je.st
news
Tag: clovis
Premarket Biotech Digest: Clovis A Buy, Cellceutix Rallies, Pfizer's Avelumab Milestone
2015-11-27 17:06:01| Biotech - Topix.net
Click this link to find out how much you can save). . Clovis Oncology suffered a major setback earlier this month.
Tags: buy
digest
biotech
milestone
Clovis Blowup Conjures Bad Biotech Memories of ImClone Darkness
2015-11-16 20:08:16| Biotech - Topix.net
As with Imclone, the Clovis mess could have a long-lasting, negative effect on the entire biotech sector. For those too young to remember, ImClone, in 2001, was cruising towards FDA approval of its targeted colon cancer drug Erbitux.
Tags: bad
memories
darkness
biotech
ASCO 2015: NDA coming soon as Clovis unveils data in ovarian, NSCLC
2015-05-31 23:38:49| Logistics - Topix.net
Clovis Oncology Inc. took a big step ahead in preparations for filing its new drug application for the experimental non-small cell lung cancer therapy, rociletinib, showcasing data from an ongoing phase II study testing the drug in a group of heavily pre-treated patients, most of whom had developed resistance to current treatments. The company, which plans to use the data as part of a rolling submission to the FDA slated to begin in June, provided the update at the American Society of Clinical Oncology annual meeting.
Clovis Oncology's Phase 2 Studies of Rucaparib in Ovarian Cancer...
2015-05-30 21:49:00| Logistics - Topix.net
Clovis Oncology today announced updated Phase 2 results from two ongoing clinical studies with rucaparib: ARIEL2 and Study 10. Rucaparib is the Company's investigational oral, potent, small molecule inhibitor of PARP1 and PARP2 being developed for the treatment of advanced ovarian cancer, specifically in patients with BRCA mutations and other DNA repair deficiencies beyond BRCA, commonly referred to as "BRCA-like." Updated data from the ARIEL2 study in 204 patients with advanced ovarian cancer are being presented Monday in an oral presentation by Professor Iain McNeish at the 2015 American Society of Clinical Oncology annual meeting in Chicago.
Tags: studies
phase
cancer
ovarian
Clovis Oncology Announces Data Presentations at 2015 ASCO Annual Meeting
2015-05-14 10:21:11| Logistics - Topix.net
Clovis Oncology today announced that two oral presentations and six poster sessions highlighting updated results and trial designs from clinical studies of the company's three compounds in advanced clinical development are being presented at the 2015 American Society of Clinical Oncology Annual Meeting, which will take place May 29-June 2, 2015 in Chicago.
Tags: data
meeting
annual
presentations